Handbook

O

Orforglipron

Orforglipron is currently being researched as a once daily oral glucagon like peptide-1 (GLP-1) receptor agonist

Unlike injectable GLP-1s Orforglipron is a non-peptide small molecule, making simpler to administer without the need for injections or refrigeration

It can be taken at any time of day, with or without food or water restrictions, and has a half-life of 29 to 49 hours

Orforglipron mimics the effects of the GLP-1 hormone by binding to GLP-1 receptors in the body. This stimulates insulin release from the pancreas in response to meals, inhibits glucagon secretion (which raises blood sugar), slows gastric emptying to promote feelings of fullness, and reduces appetite

As a partial agonist, it primarily affects cyclic AMP signaling, which may lead to less receptor desensitization compared to full agonists

It’s primarily being researched for managing type 2 diabetes (by improving glycemic control) and chronic weight management in adults with obesity or overweight with at least one weight-related condition, such as hypertension or obstructive sleep apnea

Research application

Copied from the handbook as research notes. and not instructions.

  • Weeks: 1-2: 3mg once daily
  • Weeks: 3-4: 6mg once daily
  • Weeks: 5-8: 12mg once daily
  • Weeks: 9-12: 18mg once daily
  • Weeks: 13-16: 24mg once daily

Week 17+: 36 mgonce daily

  • Type 2 Diabetes: Researched tested include 3 mg, 12mg, and 36mg daily for 40 weeks

Weight Management: Researched tested 12mg, 24mg, or 36mg daily were studied, with higher doses achieving up to 12% body weight reduction over 72 weeks in adults with obesity or overweight with comorbidities

Unless other wise noted intermuscular (IM) peptides are commonly administered via subcutaneous (SQ) injection with 30-31 gauge syringes

From @BowTiedYukon

Read this first

The information provided is for educational and informational purposes only and is not medical advice. Always consult with your physician or a qualified healthcare provider before starting any health protocol or using any peptides

YOU assume full responsibility for YOUR actions and decisions. Do YOUR own research and make informed choices in consultation with a licensed medical professional

This guide is an independent work created by the author. It is not affiliated with, endorsed by, or associated with any company or organization

All peptides discussed are intended for research use only. They are not intended for human or animal consumption or for use in any diagnostic or therapeutic purposes

Unless other wise noted intermuscular (IM) peptides are commonly administered via subcutaneous (SQ) injection with 30-31 gauge syringes

This app is an alphabetical reader for BowTiedYukon’s free Peptide Handbook. It is not affiliated with Elite Research USA. His profile lists the code YUKON10.

@BowTiedYukon